a study on High Blood Pressure
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Portopulmonary Hypertension Macitentan
For people ages 18 years and up
Main Inclusion Criteria:
Main Exclusion Criteria:
This step makes sure spammers don’t flood our inbox
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT02382016.
© The Regents of the University of California